Pharmaceutical sector puts spring into September
There have been signs of renewed activity in the pharmaceuticals sector in September, with two significant deals announced in recent weeks.On 3 September, Peplin Inc (Peplin) announced a
There have been signs of renewed activity in the pharmaceuticals sector in September, with two significant deals announced in recent weeks.
On 7 September, Sigma Pharmaceuticals launched a $297m capital raising, following on from Sigma's acquisition of a Bristol-Myers Squibb unit in Melbourne. The money raised will be used to fund this recent acquisition and to reduce gearing.
Mallesons Stephen Jaques is acting for the underwriter, Deutsche Bank, on the Sigma capital raising. Partner David Friedlander is leading the Mallesons team, supported by senior associates Adam Levine and Simon Panegyres and solicitors Jessica Hudson and Amanda Isouard.
Deal summary:
Peplin/ LEO Pharma merger
Sigma Pharmaceuticals capital raising
Key Players:
Corrs Chambers Westgarth, Mallesons Stephen Jaques, Gilbert + Tobin, Deutsche Bank